Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Blokhin's Russian Cancer Research Center
Grupo Espanol de Investigacion en Sarcomas
The First Affiliated Hospital of Xinxiang Medical College
Instituto Nacional de Cancer, Brazil
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Base Therapeutics (Shanghai) Co., Ltd.
Ruijin Hospital
Grupo Espanol de Investigacion en Sarcomas
South Plains Oncology Consortium
Istanbul University
Cairo University
AlaMab Therapeutics (Shanghai) Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Peking University People's Hospital
Peking University People's Hospital
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Sun Yat-sen University
Assistance Publique - Hôpitaux de Paris
Lee's Pharmaceutical Limited
Samsung Medical Center
Peking University People's Hospital
National Cancer Center, Korea
Assaf-Harofeh Medical Center
Henan Cancer Hospital
Grupo de Apoio ao Adolescente e a Crianca com Cancer
Sun Yat-sen University
Tianjin Medical University Cancer Institute and Hospital
Universitaire Ziekenhuizen KU Leuven
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hospital Santa Marcelina
Alaunos Therapeutics
Tata Memorial Hospital
Tata Memorial Hospital
Gustave Roussy, Cancer Campus, Grand Paris